Table 3.
Histopathological result and molecular status of metaplastic breast carcinoma.
No. of patients, |
||
---|---|---|
n = 14, n(%) | ||
Histological subtype | Squamous cell carcinoma | 6 (42.9%) |
Spindle cell carcinoma | 2 (14.3%) | |
Metaplastic carcinoma with mesenchymal differentiation | 1 (7.1%) | |
Metaplastic carcinoma of no specific type | 5 (35.7%) | |
Molecular Status | ER (+) PR/HER2 (−) | 2 (14.3%) |
ER/PR (+) HER2 (−) | 1 (7.1%) | |
ER/PR (−) HER2 (+) | 1 (7.1%) | |
Triple negative | 10 (71.4%) |